Document is current
Any future updates will be listed below
-
Authors
Zbyszynski, Pawel
Toraason, Inger
Repp, Lauren
Kwon, Glen S.
-
Funding
Funding for this research was provided by:
University of Wisconsin Carbone Cancer Center (P30 CA014520.)
- License Information
-
More Information
Article History
Received: 22 April 2019
Accepted: 12 June 2019
First Online: 8 July 2019
Competing interests
: GSK and PZ are among co-inventors of a filed patent (filing date: Nov 12<sup>th</sup>, 2018) pertaining to clinical applications of PEG-FUD, including as an antifibrotic agent.
